The effect of post-mortem computed tomography angiography (PMCTA) on biomarkers of coronary artery disease

• Published in: Journal of Forensic and Legal Medicine
• Main Author: Woon C.K.; Omar E.; Siew S.F.; Nawawi H.M.; Kasim N.A.M.; Chainchel Singh M.K.
• Format: Article
• Language: English
• Published: Churchill Livingstone 2024
• Online Access: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85184070958&doi=10.1016%2fj.jflm.2024.102654&partnerID=40&md5=9505d80342def1062099b1fd2b129e64

Coronary atherosclerosis is due to build-up of plaque within the coronary arteries. Post-mortem computed tomography (PMCT) allows non or minimally invasive visualization of abnormalities prior to an autopsy, however PMCT-angiography (PMCTA) greatly enhances relevant findings, especially in viewing the cardiovascular system which is important in the diagnosis of coronary atherosclerosis. Contrast media used in PMCTA however has been reported to cause distortion of tissue which may interfere with post-mortem investigation outcomes. A cross sectional study to investigate the effect of PMCTA on tissue biomarkers in coronary arteries was performed involving cases brought in dead to the Institute and Accident and Emergency Unit. Sixty-three autopsy cases were included in this study, whereby 18 cases underwent PMCT while 45 cases underwent PMCTA. The subjects subsequently had a conventional autopsy where coronary artery sections were collected for standard histological examination and immunohistochemistry examination for endothelial inflammatory (CD36), prothrombogenic (TPA) and plaque stability (MMP-9) markers. The subjects consisted of 55 males and 8 females with a mean age ±SD of 49 ± 18.11 years. There were no significant differences in the coronary artery endothelial expression of CD36, MMP-9 and TPA between PMCT and PMCTA subjects. PMCTA does not alter CD36, TPA and MMP-9 markers supporting the safe use of PMCTA in post-mortem examinations. © 2024 Elsevier Ltd and Faculty of Forensic and Legal Medicine